Investment in healthcare artificial intelligence startups and companies focused on mental health and wellness soared in the second quarter as both sectors hit funding highs, according to a new report.
With technological advancement occurring at an increasingly breakneck pace, it’s natural the number of life science and technology innovation clusters is growing as well. These clusters result from the increasing recognition that innovators do not perform at their best in widely dispersed buildings. Instead, they gain most from highly specialized facilities and collaborative ecosystems that foster cross-fertilization of ideas.
The therapies saved roughly 90 percent of the patients who received them early in the course of infection. Doctors hope patients will seek out the cures, ending the outbreak.
Rising drug prices and ever-increasing costs are two of the most debated subjects in healthcare. The Centers for Medicare and Medicaid Services (CMS) predicts (PDF link) that we will see 6.1 percent annual prescription drug cost increases until at least 2027. CMS expects healthcare spending as a whole to grow by 5.7 percent per year for the same timeframe.
Our map shows the top VC investing in tech companies in each state, from 500 Startups in California to Lerer Hippeau in New York.
Researchers have been able to coax human breast cancer cells to turn into fat cells in a new proof-of-concept study in mice.
To achieve this feat, the team exploited a weird pathway that metastasising cancer cells have; their results are just a first step, but it’s a truly promising approach.
Thank you to BioHealth Innovation, Inc. for this incredible experience. I learned so much from these brilliant minds, and look forward to an ongoing relationship.
Applications Due September 5
The Commercialization Readiness Pilot (CRP) Program is now open and accepting applications for the September 5th NIH SBIR/STTR receipt date. NHLBI will accept applications via PAR-19-333, PAR-19-334, and PAR-19-335 from small businesses that have had an active NHLBI SBIR or STTR Phase II or Phase IIB award within the last 36 months.
This opportunity provides up to $300,000 (PAR-19-334) or $500,000 (PAR-19-333, PAR-19-335) to support technical assistance and later stage research and development (R&D) not typically supported through Phase II or Phase IIB grants or contracts including:
- Independent replication of key studies
- Investigational New Drug (IND)-enabling studies
- Clinical studies, manufacturing costs
- Regulatory assistance
Contact NHLBI Small Business Program Coordinator Mike Pieck (NHLBI_SBIR@mail.nih.gov) with questions.
Bayer said today it has agreed to acquire BlueRock Therapeutics for up to $600 million in a deal designed to catapult the buyer into leadership in cell therapies, nearly three years after joining with healthcare investment firm Versant Ventures to launch the company.
This just in: Maryland’s internet is the least likely to cut out right at the juicy scene in ‘The Bachelor’. According to web service provider assessment group Highspeedinternet.com, Maryland has the fastest internet speed in the country.